+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Role of γ-glutamyl cyclotransferase as a therapeutic target for colorectal cancer based on the lentivirus-mediated system



Role of γ-glutamyl cyclotransferase as a therapeutic target for colorectal cancer based on the lentivirus-mediated system



Anti-Cancer Drugs 27(10): 1011-1020



Human GGCT (γ-glutamyl cyclotransferase) has been shown to be upregulated in most tumors, but its role in colorectal cancer (CRC) is poorly understood. Thus, CRC cell lines, including HCT116 and SW1116, were chosen to investigate the role of GGCT by constructing a GGCT silencing cells model using lentivirus-mediated RNA interference. The knockdown efficiency was confirmed by reverse transcription-quantitative PCR and a western blot assay. Then, a set of biological functions of GGCT silencing on CRC cell was assessed by MTT, colony-formation assay, and flow cytometry analysis. Further, western blot and Pathscan intracellular signaling were used to detect intracellular signaling associated with cell growth and apoptosis induced by GGCT knockdown. In addition, the clinical chemotherapeutic drug 5-fluorouracil was used to investigate the impact of GGCT silencing on drug sensitivity by an Annexin V/7-AAD double-staining assay. The results of the analysis indicated that GGCT silencing significantly suppressed cell proliferation and arrested cell cycle at the G0/G1 phase by regulating the expression of p21, p27, and cyclin E. Moreover, GGCT silencing triggered the apoptosis of CRC cells by activating caspase-3 and cleaved poly-ADP-ribose polymerase pathways and downregulating the phosphorylation proline-rich Akt substrate of 40 kDa (PRAS40) expression levels. Furthermore, GGCT silencing combined with 5-fluorouracil treatment further induced the apoptotic rate of CRC cells. These findings suggest that GGCT may be a promising diagnostic and therapeutic target for CRC by activating the apoptotic pathway.

(PDF emailed within 0-6 h: $19.90)

Accession: 058791887

Download citation: RISBibTeXText

PMID: 27500968

DOI: 10.1097/CAD.0000000000000407


Related references

C7orf24/gamma-glutamyl cyclotransferase as a molecular target for cancer chemotherapy. Nihon Rinsho. Japanese Journal of Clinical Medicine 70 Suppl 8: 723-727, 2013

Localization and characterization of γ-glutamyl cyclotransferase in cancer cells. Molecular Medicine Reports 2(3): 385-391, 2009

The role of Reg IV in colorectal cancer, as a potential therapeutic target. Contemporary Oncology 19(4): 261-264, 2015

Possible Role and Therapeutic Target of PDGF-D Signalling in Colorectal Cancer. Cancer Investigation 2019: 1-14, 2019

The role of tumor angiogenesis as a therapeutic target in colorectal cancer. Expert Review of Anticancer Therapy 18(3): 251-266, 2018

Oncogenic role and therapeutic target of leptin signaling in colorectal cancer. Expert Opinion on Therapeutic Targets 18(8): 961-971, 2015

The insulin-like growth factor system as a therapeutic target in colorectal cancer. Annals of Oncology 13(3): 349-356, 2002

Reduced seed region-based off-target activity with lentivirus-mediated RNAi. Rna 16(5): 879-884, 2010

The influence of lentivirus-mediated CXCR4 RNA interference on hepatic metastasis of colorectal cancer. International Journal of Oncology 44(6): 1861-1869, 2014

Proteomic profiling of mammary carcinomas identifies C7orf24, a gamma-glutamyl cyclotransferase, as a potential cancer biomarker. Journal of Proteome Research 9(8): 3941-3953, 2010

Proteomic-based identification of the APC-binding protein EB1 as a candidate of novel tissue biomarker and therapeutic target for colorectal cancer. Journal of Proteomics 75(17): 5342-5355, 2013

Establishment and application of lentivirus luciferase reporter-mediated miRNA target gene screening system. Zhongguo Shi Yan Xue Ye Xue Za Zhi 20(1): 159-163, 2012

Lentivirus-mediated knockdown of rhomboid domain containing 1 inhibits colorectal cancer cell growth. Molecular Medicine Reports 12(1): 377-381, 2016

Lentivirus‑mediated knockdown of MeCP2 inhibits the growth of colorectal cancer cells in vitro. Molecular Medicine Reports 13(1): 860-866, 2016

Lentivirus-mediated somatic recombination and development of a novel mouse model for sporadic colorectal cancer. Genes, Chromosomes and Cancer 55(7): 577-590, 2017